Category: On-Demand Webinar

Join this free webinar, where you will learn how to: Recognize what’s new in PCQI 2.0, and why it matters. Utilize new tools such as FDA’s Appendix 1 hazard list. Leverage the updated guidance to enhance your monitoring, corrective action, verification, and recordkeeping practices. Ensure your preventive controls program and PCQI training reflect the latest

Understanding and implementing Unique Device Identification (UDI) requirements can be one of the most complex challenges for medical device professionals. In this session, our labeling and regulatory experts will break down the logic behind medical device labeling and guide you through the most common pitfalls that can delay compliance or create costly errors.  Join us

Join us for an in-depth webinar that unpacks the essential requirements of Cosmetic Regulation (EC) No. 1223/2009, the cornerstone of cosmetic product safety and compliance in the European Union. Designed for manufacturers, brand owners, and regulatory professionals, this session provides a clear, step-by-step explanation of the regulation’s key provisions and how to achieve and maintain

Failure to adequately address observations from an FDA inspection can lead to serious consequences, including warning letters; regulatory meetings; import alerts; seizures of products and operational shutdowns. Responding appropriately to the FDA can mean the difference between continuing operations without interruption and increased regulatory oversight. The purpose of this presentation is to address what you

Fragrance and flavor ingredients are central to cosmetics and personal care products, but they’re also highly regulated due to their complexity and potential allergens. With the 51st Amendment to the International Fragrance Association (IFRA) Standards going into effect on October 30, 2025, the time to act is now.  This significant update introduces new ingredient restrictions,

Did you know that two of the most common reasons food products are refused entry into the U.S. are labeling mistakes and illegal food additives? Many companies don’t discover that their products are not permitted in the U.S. market until it is too late, and they are detained at port. Recent FDA actions add to the

Health Canada Master Files (MFs) are a powerful tool for protecting proprietary information while streamlining regulatory submissions — but navigating their requirements can be complex. Understanding how to prepare, submit, and maintain a compliant Master File is essential to safeguard intellectual property, avoid costly delays, and accelerate product approvals in Canada’s competitive pharmaceutical product market.

Nothing derails supply chains like FDA import detentions. This webinar will help you understand what triggers detentions, how Import Alerts work, and what steps you can take to keep your medical devices moving across borders without delays. Learn best practices for documentation, product coding, and how to respond if issues arise—all backed by real-world scenarios.

The Ministry of Economic Affairs is pleased to announce a webinar presented by Registrar Corp: An Update on US FDA Regulations, Best Practices, and Common Challenges – and Recommended Solutions for the Foreign Exporter. As the U.S. Food and Drug Administration (FDA) continues to update and refine regulations for food and cosmetic products, it’s more

FDA Investigators (Consumer Safety Officers) inspect manufacturers for many reasons, but their process follows consistent guidelines. This webinar will focus on what to expect from an investigator during an inspection, what they may be thinking, and how you can prepare to ensure the inspection goes smoothly.  Topics include:  Who FDA investigators are and how they

Perfect for newcomers and professionals seeking a refresher, this webinar provides a clear, practical introduction to the regulatory framework that governs medical devices in the United States. Learn how the FDA classifies devices, what pathways exist for market entry, and the compliance obligations every manufacturer must understand. 

FDA inspections are inevitable for drug manufacturers — whether to secure pre-approval for a new product, ensure GMP compliance, follow up on post-market reports, or investigate complaints and recalls. While the reason may differ, FDA investigators follow established procedures, and knowing what to expect can make the difference between a smooth inspection and a disruptive

Led by the FDA Expert Who Trained FDA Staff on Food Safety Culture Food science has advanced, and FSMA has been law since 2011. Most U.S. food manufacturers now maintain a Food Safety Plan and designate a Preventive Controls Qualified Individual. Yet major recalls and outbreaks keep happening. What’s missing? Even the world’s biggest brands

Did you know that two of the most common reasons food products are refused entry into the U.S. are labeling mistakes and illegal food additives? Many companies don’t discover that their products are not permitted in the U.S. market until it is too late, and they are detained at port. Recent FDA actions add to the

Canada’s cosmetics regulations are undergoing major changes in 2025, and companies that sell into the Canadian market need to adapt quickly to remain compliant. From new labeling requirements to fragrance allergen disclosures and enhanced safety protocols, Health Canada’s updated rules will impact how products are formulated, packaged, and marketed.  In this webinar, our regulatory expert

The Generic Drug User Fee Amendments (GDUFA) are central to FDA oversight of generic drug manufacturers, but navigating the requirements isn’t always straightforward. Self-identification, program fees, and DMF submissions create recurring challenges that can be costly if misunderstood or overlooked.     In this session, Melissa Sayers, Drug Regulatory Manager, will simplify the complexities of GDUFA

Drug registration and listing renewals are non-negotiable for maintaining FDA compliance—and missing even one step can result in product inactivation or regulatory action. This webinar is designed for manufacturers, private labelers, and compliance professionals who need clear, actionable guidance on staying ahead of FDA requirements. Our experts will break down what’s required, what’s commonly missed,

Registrar Corp and the U.S. Commercial Service of the U.S. Embassy in Australia hosted an exclusive webinar tailored for food and beverage exporters across Oceania looking to enter and succeed in the U.S. market. This session will feature opening remarks from senior representatives of the U.S. Commercial Service and Austrade, followed by expert insights from

Overview of two of FDA’s most effective enforcement tools: detention in port and import alerts. We will discuss how and why products are detained and circumstances under which the detention can be resolved and the products released. We will also discuss FDA’s system of import alerts, why companies are placed on import alerts, and how

Join us for this informative webinar designed for China-based pharmaceutical and API manufacturers preparing Master File (MF) submissions to global regulatory agencies, including the U.S. FDA, Health Canada, EMA, and others. This session will provide essential insights into the MF lifecycle and help ensure your submissions are secure, complete, and compliant.  Topics include:  Types of

Avoid Costly Delays and Master the FDA Import Process for Drugs and Devices. Drug and device shipments are often delayed or denied entry into the U.S. due to issues like incomplete documentation, labeling mistakes, or active Import Alerts. For companies importing FDA-regulated products, a solid understanding of the import process—and how to effectively respond to

Fragrance and flavor ingredients are central to cosmetics and personal care products, but they’re also highly regulated due to their complexity and potential allergens. With the 51st Amendment to the International Fragrance Association (IFRA) Standards going into effect on October 30, 2025, the time to act is now.  This significant update introduces new ingredient restrictions, clarifications, and compliance changes.

Join us for an in-depth webinar designed for medical device manufacturers navigating FDA requirements related to product labeling, traceability, and Unique Device Identification (UDI). Whether you’re preparing your first UDI submission or reassessing your compliance program, this session offers a structured, strategic overview of what the FDA expects—and how to implement it correctly across your

Join us for a webinar introducing Cosmetri for Brand Managers, the innovative software platform with a focus on the specific needs of brand managers in the beauty and personal care industry. Learn how this all-in-one software will streamline your product development process, manage regulatory compliance, and speed up your product launches.    We will focus